Crossmark

E2f1 deletion attenuates infarct-induced ventricular remodeling without affecting O-GlcNAcylation

Crossref DOI link: https://doi.org/10.1007/s00395-019-0737-y

Published Online: 2019-05-31

Published Print: 2019-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Dassanayaka, Sujith

Brittian, Kenneth R.

Jurkovic, Andrea

Higgins, Lauren A.

Audam, Timothy N.

Long, Bethany W.

Harrison, Linda T.

Militello, Giuseppe

Riggs, Daniel W.

Chitre, Mitali G.

Uchida, Shizuka

Muthusamy, Senthilkumar

Gumpert, Anna M.

Jones, Steven P. https://orcid.org/0000-0001-5376-8089
Funding

Funding for this research was provided by:

National Institutes of Health (R01 HL131647)

National Institutes of Health (P30 GM127607)

National Institutes of Health (P01 HL078825)

American Heart Association (14PRE19710015)
License Information

Text and Data Mining valid from 2019-05-31
More Information

Article History

Received: 28 February 2019

Accepted: 20 May 2019

First Online: 31 May 2019

Compliance with ethical standards

:

: The authors declare that they have no competing interest.